Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.31 - $0.48 $462 - $715
1,491 Added 0.93%
162,565 $56,000
Q2 2023

Aug 08, 2023

SELL
$0.43 - $0.77 $25,857 - $46,302
-60,133 Reduced 27.18%
161,074 $75,000
Q1 2023

Apr 10, 2023

BUY
$0.62 - $1.1 $98,544 - $174,837
158,943 Added 255.27%
221,207 $150,000
Q4 2022

Feb 07, 2023

SELL
$0.84 - $100.75 $186,955 - $22.4 Million
-222,566 Reduced 78.14%
62,264 $65,000
Q3 2022

Nov 14, 2022

BUY
$4.61 - $116.0 $2,162 - $54,404
469 Added 0.16%
284,830 $1.16 Million
Q2 2022

Aug 01, 2022

BUY
$3.99 - $7.22 $125,054 - $226,289
31,342 Added 12.39%
284,361 $1.61 Million
Q1 2022

May 09, 2022

BUY
$5.28 - $9.17 $2,882 - $5,006
546 Added 0.22%
253,019 $1.6 Million
Q4 2021

Feb 08, 2022

SELL
$6.86 - $9.65 $204,126 - $287,145
-29,756 Reduced 10.54%
252,473 $2.24 Million
Q3 2021

Nov 12, 2021

SELL
$7.21 - $10.49 $1.27 Million - $1.85 Million
-176,372 Reduced 38.46%
282,229 $2.18 Million
Q2 2021

Jul 28, 2021

BUY
$8.48 - $13.61 $683,700 - $1.1 Million
80,625 Added 21.33%
458,601 $4.41 Million
Q1 2021

May 14, 2021

BUY
$12.96 - $19.75 $1.88 Million - $2.87 Million
145,111 Added 62.32%
377,976 $5.13 Million
Q4 2020

Feb 12, 2021

BUY
$12.74 - $18.49 $169,199 - $245,565
13,281 Added 6.05%
232,865 $3.34 Million
Q3 2020

Nov 12, 2020

SELL
$5.86 - $18.47 $3,633 - $11,451
-620 Reduced 0.28%
219,584 $4.06 Million
Q2 2020

Aug 13, 2020

BUY
$3.79 - $6.08 $834,573 - $1.34 Million
220,204 New
220,204 $1.27 Million

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0

About TFF Pharmaceuticals, Inc.


  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.66M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.